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Abstract
Purpose
Phosphorus is an essential nutrient involved in many pathobiological processes. Less than
1% of phosphorus is found in extracellular fluids as inorganic phosphate ion (Pi) in solution.
High serum Pi level promotes ectopic calcification in many tissues, including blood vessels.
Here, we studied the effect of elevated Pi concentration on macrophage polarization and
calcification. Macrophages, present in virtually all tissues, play key roles in health and dis-
ease and display remarkable plasticity, being able to change their physiology in response to
environmental cues.
Methods and results
High-throughput transcriptomic analysis and functional studies demonstrated that Pi
induces unpolarized macrophages to adopt a phenotype closely resembling that of alterna-
tively-activated M2 macrophages, as revealed by arginine hydrolysis and energetic and anti-
oxidant profiles. Pi-induced macrophages showed an anti-calcifying action mediated by
increased availability of extracellular ATP and pyrophosphate.
Conclusion
We conclude that the ability of Pi-activated macrophages to prevent calcium-phosphate
deposition is a compensatory mechanism protecting tissues from hyperphosphatemia-
induced pathologic calcification.
Introduction
Phosphorus is an essential nutrient involved in many biological processes, including cell sig-
naling, nucleic acid synthesis, energy metabolism, membrane function, and bone mineraliza-
tion. Phosphorus is found in hard tissues (~85%), soft tissues (~14%), and extracellular fluids
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(~1%)[1]. The majority of phosphorus present in extracellular fluids exists in solution as a free
phosphate ion, called inorganic phosphate (Pi). Plasma Pi has a concentration of 0.8–1.5
mmol/L, and exists in three forms: bound to proteins, complexed to cations, and ionized.
Serum phosphate concentration is the outcome of the balance among phosphate absorption
from the intestine, mobilization from bone, and renal excretion in urine [2]. Phosphate
homeostasis is mainly regulated by phosphatonins, including vitamin D, parathyroid hormone
(PTH), and fibroblast growth factor 23 (FGF23)[3].
Abnormally high serum phosphate is a pathologic condition called hyperphosphatemia.
Hyperphospatemia can result from: 1) increased phosphate intake (eg, enema or vitamin D
intoxication), 2) decreased phosphate excretion (associated with renal failure and hypopara-
thyroidism), 3) disorders that shifts intracellular phosphate to the extracellular space (includ-
ing massive hemolysis), or genetic causes[4]. Acute hyperphosphatemia can cause calcification
in soft tissues such as the myocardium, lung, and occasionally the liver[5]. In contrast, chronic
hyperphosphatemia promotes calcification in many tissues, particularly blood vessels, kidney,
bone, skin, joints, and the heart[6]. Elevated phosphate has long been recognized as an major
risk factor for all-cause and cardiovascular mortality in patients with chronic kidney disease
(CKD)[7]. Moreover, in recent years, this observation has been extended to the general popu-
lation, where serum phosphate has been linked to the severity of coronary atherosclerosis,
increased carotid intima thickness and left ventricle hypertrophy[8,9].
Macrophages are present in virtually all tissues and have immune functions as well as vital
homeostatic roles, such as erythrocyte clearance [10]. Tissue-resident macrophages are collec-
tively known as the mononuclear phagocyte system. All these myeloid linage cells have specific
names depending on their location, for example Kupffer cell in liver, Langerhans cell in skin
and mucosa, histiocyte in connective tissue, microglia in the central nervous system, and oste-
oclasts in bone[11–14]. Macrophages display remarkable plasticity and can change their physi-
ology in response to environmental cues[15], giving rise to different cell populations with
distinct functions[16]. For example, tissue-resident monocytes are activated by TH1 and TH2
cytokines to respectively form M1φs and M2φs, considered to represent the extremes of the
heterogeneous spectrum of macrophage subsets[17]. Other macrophages subtypes include oxi-
dized phospholipid-activated Mox, CXCL4-activated M4, and hemoglobin-activated M(Hb)
macrophages[18,19].
Age-dependent vascular calcification is a major independent predictor of morbimortality
associated with cardiovascular disease [8,9]. Intimal calcification, a frequent process in athero-
sclerosis, is associated with the presence of macrophages in lipid-rich areas of atherosclerotic
plaques [20]; moreover, different stages in the atherosclerosis progression are associated with
the presence of distinct macrophage subtypes [21]. The prevailing view is that macrophages
promote intimal calcification in part by releasing substances that induce osteogenic differenti-
ation and mineralization of vascular smooth muscle cells (VSMCs) [22,23]. However, a recent
report demonstrated that alternatively-activated macrophages (M2φs) have an anti-calcifying
activity not elicited by classically-activated macrophages (M1φs)[24]. Since hyperphosphate-
mia is a common condition that predisposes to calcification, in this study we analyzed whether
high Pi concentration stimulates macrophage activation and the effects of Pi-induced macro-
phages on ectopic calcification.
Materials and methods
Mice
Male mice aged 8 to 9 weeks were used in this study (C57BL/6 background, Charles River
Laboratories). Animal studies were approved by the Centro Nacional de Investigaciones
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Cardiovasculares (CNIC) ethics committee and conformed to directive 2010/63EU and rec-
ommendation 2007/526/EC regarding the protection of animals used for experimental and
other scientific purposes, enforced in Spanish law under RD1201/2005.
Isolation and polarization of macrophages from mouse bone marrow
Mice were euthanized by carbon dioxide inhalation to obtain tibiae and femurs. Bone-mar-
row-derived macrophages (BMDMs) were obtained by flushing mouse tibiae and femurs with
ice-cold PBS and passing the suspension through a cell strainer with a 70-μm cut-off[25]. Cells
were seeded on non-treated cell culture plates containing10 mL complete DMEM (DMEM,
supplemented with 1 mmol/L L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin,
and 10% (v/v) FBS) supplemented with 15% L929-cell-conditioned medium as a source of
macrophage colony-stimulating factor (M-CSF) (L929 cells from American Type Culture Col-
lection, Ref. CCL-1™). Cultures were incubated at 37˚C, 5% CO2 for 7 days, at which time
*95% were CD11b+ BMDMs (unpolarized macrophages: M0φs). To obtain MPiφs, M0φs
were washed and cultured over the indicated period in complete DMEM supplemented with
1.6mmol/LPi (final Pi concentration, 2.5mmol/L). Control M0φs were incubated with com-
plete DMEM. In both cases, the source of M-CSF was maintained.
Quantitative real-time RT-PCR
Total RNA was isolated from macrophages with QIAzol lysis reagent (Qiagen, Madrid, Spain).
After DNase treatment, 2μg RNA was reverse transcribed with the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Madrid, Spain). Quantitative real-time poly-
merase chain reaction was performed using Power SYBR Green Mix on 384-well clear optical
reaction plates, using the ABI PRISM 7900HT sequence detection system according to the
manufacturer´s instruction for calibrator normalization (Applied Biosystems). All reactions
were performed in triplicate. The primers used for amplification were as follows: (1) iNOS
(NM_010927.3): 50-GGA TCT TCC CAG GCA ACC A-30 (forward), 50-TCC ACA ACT CGC
TCC AAG ATT-30 (reverse); (2) ArgI (NM_007482.3): 50-CAG AAG AAT GGA AGA GTC AG-
30 (forward), 50-CAG ATA TGC AGG GAG TCA CC-30 (reverse); (3) eNPP1 (NM_008813): 50-
GGATTGTGCCAATAAGGACT-30 (forward), 50-CAAGAACTGTTGCTGCTGGAG-30 (reverse);
(4) TNAP (NM_007431): 50-CTATGTCTGGAACCGCACTGA-30 (forward), 50- AGCCTTTGA
GGTTTTTGGTCA-30 (reverse); (5) eNTPD1 (NM_009848): 50-AGCCTCCACACAGATCACCT
T-30 (forward), 50- GCCACCACTTGAAACCTGAAT-30 (reverse); (6) HIF-1α (NM_010431.2):
5'-CAAGTT GGAACTGGTGGAAAA-3' (forward), 5'-GATTCATCAGTGGTGGCAGTT-3'
(reverse); (7) PGC-1β (NM_133249.2): 5'-CCTGGA TAC AGA GACCCA CAA-3' (forward),
5’-CCA AGA GAG TCG CTT TGT GAC-3’ (reverse). Expression was quantified by the com-
parative Ct method, with correction for the expression of the endogenous control gene acidic
ribosomal phosphoprotein P0 (RPLP0, accession number NM_007475).
RNAseq library preparation, sequencing, and FastQ file generation
Total RNA (500 ng) was used to generate barcoded RNA-seq libraries using the TruSeq RNA
Sample Preparation Kit v2 (Illumina). Briefly, poly A+ RNA was prepared by two rounds of
purification with poly-T oligo-attached magnetic beads, followed by fragmentation and first
and second cDNA strand synthesis. Next, cDNA 3’ ends were adenylated and the adapters
ligated, followed by PCR library amplification. Finally, the library size was checked using the
Agilent 2100 Bioanalyzer DNA 1000 chip and RNA concentration was determined using the
Qubit1 fluorometer (Life Technologies). Libraries were sequenced on a HiSeq2500 (Illumina)
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to generate 60-base single reads. FastQ files for each sample were obtained using CASAVA
v1.8 (Illumina).
Immunnobloting
Macrophage lysates were prepared in lysis buffer (0.1% SDS, 25 mmol/L Tris-HCl pH 7.4, and
protease inhibitors) and 40 μg of protein was separated by SDS-PAGE and blotted to polyviny-
lidenedifluoride membrane. Rabbit monoclonal anti-eNTPD1 (1/5000, ab108248, Abcam,
Cambridge, United Kindom) and rabbit polyclonal anti-TNAP (1μg/mL, ab65834, Abcam)
were used according to manufacturers’ instructions and as described[26].
Flow cytometry
Macrophages were trypsinized and Fc blocking (eBioscience 14–0161) was performed before
staining with PE-Cy7-conjugatedanti-F4/80 (0.01 g/L, BioLegend 123114) or FITC-conjugated
anti-CD11b (0.01 g/L, BD Pharmingen 553310). For negative control, cells were stained with
the corresponding isotype control antibodies (BioLegend 400522,0.01 g/L and BD Pharmingen
553988, 0.01 g/L, respectively). Cells were analyzed using a LSRII Fortessa flow cytometer.
Results were analyzed using BD Diva and FlowJo software.
ATP, ADP and PPi quantification
PPi and ATP were quantified as described [24,26]. PPi was measured with an enzyme-linked
bioluminescence assay in which PPi reacts with adenosine 5-phosphosulfate (A5508, Sigma-
Aldrich) in the presence of ATP sulfurylase (A8957, Sigma-Aldrich) to generate ATP. For each
sample, the amount of PPi was obtained by subtracting the blank reading (reaction without
ATP-sulfurylase). ATP was measured by a coupled luciferin/luciferase reaction with an ATP
determination kit (Invitrogen, Paisley, United Kingdom). ADP/ATP ratio was determined
with the EnzyLight™ ADP/ATP ratio assay kit (BioAssay Systems).
Total antioxidant capacity and GSH and GSSG quantification
Total antioxidant capacity was quantified with the Quantichrom Antioxidant Assay Kit (Bioas-
say Systems). Total, oxidized, and reduced glutathione was quantified with the EnzyChrom™
GSH/GSSG Assay Kit (BioAssay Systems).
Arginase and alkaline phosphatase activities
Arginase activity was quantified in lysed macrophages as described[27,28]. Macrophages were
lysed in 25 mmol/LTris-Cl buffer, pH 8 containing 0.1% Triton X-100 and protease inhibitor
cocktail (Roche; Cat. Num. 11836145001). For each 100 μL of lysis buffer containing 15 μg pro-
tein, 10 μL of 10 mmol/L MnCl2 were added, and samples were then heated at 55˚C in a water
bath for 10 minutes. L-arginine (100 μL, 0.5 mol/L) was added to each sample (total sample
volume 210 μL) and incubated at 37˚ for the indicated time. The reaction was stopped by add-
ing 800 μL of acid solution (7:3:1 H2O: H2PO4 44.6N: H2SO4 36N). After adding 40 μL of 9%
(w/v) α-isonitrosopropiophenone (dissolved in absolute ethanol), samples were heated at
100˚C for 30 minutes. Finally, the samples were cooled on ice in the dark for 10 minutes and
absorbance was read at 550 nm. For the standard curve, serial two-fold dilutions of 50 mmol/L
urea were used. Protein was quantified with the Pierce™ BCA™ Protein Assay Kit (Thermo
Scientific).
Phosphatase activity was measured with the p-nitrophenylphosphate (pNPP) Phosphatase
Assay Kit (BioAssay Systems) as described[29].
Phosphate-activated macrophages and ectopic calcification
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Calcification assays and CPD quantification
Mouse primary VSMCs were obtained and grown on sterile polystyrene 6-well culture plates
as described[30]. To obtain a passive model of calcification, confluent VSMCs were fixed as
previously described[31,32]. VSMCs were then co-cultured at 37˚C and 5% CO2 with sterile
0.4 μm polycarbonate transwell membranes (Costar) containing M0φs or MPiφs. This co-cul-
ture system allows the effect of macrophages on calcification to be studied without interference
from cell-cell interactions and VSMC activity. Macrophages and fixed VSMCs were co-incu-
bated (after washing three times) in pro-calcifying medium: DMEM supplemented with 1
mmol/L L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, 0.1% FBS and sodium
phosphate (NaH2PO4
-/Na2HPO4
2-, pH 7.4) to a final concentration of 2.5 mmol/L. The trans-
well containing previously polarized macrophages and the pro-calcifying medium were both
replaced daily over a 5-day period.
Calcium deposits were quantified as described[30]. Briefly, cells were treated overnight at
4˚C with 0.6 mol/L HCl and analyzed with the colorimetric Calcium Quantification Assay Kit
(BioAssay System, Hayward, CA).
Statistical analysis
Results are presented as means ±SE of 3–4 independent experiments using 2–3 mice per exper-
iment. Statistical significance was evaluated with GraphPad Prism 5 by means of unpaired Stu-
dent’s t-test with Welch correction or ANOVA with Tukey’s multicomparison, as indicated in
figure legends. Statistical significance was assigned at P<0.05.
Results
Macrophages are activated by high Pi concentration
To investigate the effect of Pi on macrophage polarization and activation during Pi-induced
calcification, we performed in vitro assays in which unpolarized macrophages (M0φs) were
incubated for 3 days in medium supplemented with a range of Pi concentrations. Pi dose-
dependently induced the mRNA expression of the M2φ marker arginase 1 (ArgI) without sig-
nificantly changing the expression of inducible nitric oxide synthase (iNos), a M1φ marker
(Fig 1A). Time course experiments with macrophages exposed to 2.5 mmol/L Pi over 7 days
revealed a progressive increase in ArgI mRNA starting after 4 days (Fig 1B). Moreover, flow
cytometry analysis revealed significantly higher levels of the macrophage-specific surface
markers F4/80 and CD11b on the surface of macrophages incubated with Pi (MPiφs) than on
the surface of M0φs (Fig 1C and 1D). These results indicate that high Pi concentration acti-
vates unpolarized macrophages.
MPiφs degrade arginine via Arg1
To investigate the metabolic changes provoked by Pi in macrophages, we analyzed gene
expression profiles of MPiφs and control M0φs. RNAseq analysis of macrophages derived
from 5 mice in 3 independent experiments revealed 3,270 mRNAs differentially expressed in
MPiφs versus M0φs. Of these mRNAs, 1,707 were upregulated and 1,563 downregulated in
MPiφs (S1 Table). The most stongly up-regulated mRNA in MPiφs was ArgI (900-fold),
whereas mRNA levels of iNos and arginosuccinate synthetase (an important regulatory
enzyme in the urea cycle) were increased by 3.9-fold and 5.7-fold, respectively (Fig 2A).
Hydrolysis of arginine by Arginase 1 produces urea and ornithine, the ornithine being trans-
formed to proline, an important amino acid present in collagen fibers. Consistent with this,
MPiφs showed elevated mRNA levels of five collagen genes and 4.8-fold downregulation of the
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urea transporter SLC14A1. Higher Arg1 mRNA expression in MPiφs than in M0φs was con-
firmed by qPCR (Fig 2B) and was paralleled by augmented ArgI activity, quantified as the
amount of urea produced from arginine (Fig 2C).
MPiφs display an increased energetic profile
We next analyzed the energetic profile of MPiφs. Previous studies showed that M1φs synthe-
size ATP mainly via glycolysis, whereas M2φs primarily synthesize ATP via β-oxidation of
fatty acids[33,34]. Compared with M0φs, MPiφs expressed higher mRNA transcript levels of
both HIF-1α and PGC-1β, known markers of glycolysis and β-oxidation, respectively (S1
Table and Fig 3A and 3B). This was associated with a ~1.5-fold higher amount of intracellular
Fig 1. Macrophages are activated by high Pi concentration. Unpolarized M0φs were washed three times and incubated with the indicated
concentration of Pi for 3 days (A) or incubated with 2.5 mmol/L Pi for the indicated time (B). Statistical significance was determined by one-way ANOVA
analysis of variance followed by Tukey´s multicomparison test. (C) Flow cytometry studies showing activation of M0φs after exposure to high [Pi] (2.5
mmol/L) for 7 days. (D) Quantification of CD11b and F4/80, revealing significantly higher levels of macrophage-specific surface markers on MPiφs than
on M0φs. Statistical significance was determined by Student’s t-test. Results are presented as mean ± SE of 3 independent experiments with 3 mice per
experiment.*, P<0.05; **,P<0.01; ***,P<0.001.
https://doi.org/10.1371/journal.pone.0174998.g001
Phosphate-activated macrophages and ectopic calcification
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ATP in MPiφs, with no significant difference in ADP/ATP ratio (Fig 3C). Moreover, RNAseq
revealed upregulation in MPiφs of hexokinase, phosphofructokinase, and pyruvate kinase, key
enzymes in glycolysis regulation (Fig 3A). MPiφs also showed upregulated mRNA expression
of several transporters and enzymes involved in the transport and degradation of fatty acids
Fig 2. MPiφs degrade arginine via Arg1. (A) RNAseq data summarizing fold mRNA upregulation in MPiφs of collagen types and enzymes involved
in the urea cycle. (B) Arg1 and iNOS mRNA levels. (C) Arginase activity. Statistical significance was determined by Student’s t-test. Results are
presented as mean ± SE of 4 independent experiments with 3 mice per experiment. ***, P<0.001.
https://doi.org/10.1371/journal.pone.0174998.g002
Phosphate-activated macrophages and ectopic calcification
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Fig 3. MPiφs have an enhanced energetic profile. (A) RNAseq data summarizing fold mRNA downregulation or upregulation in MPiφs of
enzymes in the main pathways involved in glucose and fatty acid catabolism. (B) mRNA levels for HIF-1α and PGC-1βmRNA levels. (C)
Intracellular ATP and ADP/ATP ratio. Statistical significance was determined by Student’s t-test. Results are presented as mean ± SE of 4
independent experiments with 3 mice per experiment. **, P<0.01; ***, P<0.001.
https://doi.org/10.1371/journal.pone.0174998.g003
Phosphate-activated macrophages and ectopic calcification
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via β-oxidation, including carnitine palmitoyltransferase I, acyl CoA dehydrogenase, and two
fatty acid transporters (Fig 3A and S1 Table).
MPiφs show increased antioxidant synthesis
Mitochondria and NADPH oxidase are two major sources of reactive oxygen species (ROS) in
macrophages. ROS include superoxide anion (O2
-) and hydrogen peroxide (H202), and the
oxidative stress they produce causes significant damage to cell structures. Cells are protected
against oxidative stress by an interacting network of antioxidant enzymes that convert super-
oxide anion into hydrogen peroxide, which is then further reduced to water. RNAseq in
MPiφs showed a 3.4-fold downregulation of Nox1, a gene that encodes NADPH oxidase 1, as
well as upregulation of antioxidant enzymes, including superoxide dismutase 3 (9.3-fold), per-
oxiredoxine 1 (3.8-fold), glutathione peroxidase 1 (1.6-fold), catalase (1.4-fold), and superox-
ide dismutase 2 (1.3-fold) (Fig 4A and S1 Table).
In addition to upregulating antioxidant enzymes, cells respond to oxidative stress by syn-
thesizing antioxidant metabolites, including uric acid and glutathione. Uric acid is an antioxi-
dant produced from xanthine by the enzyme xanthine dehydrogenase. Glutathione exists in
reduced (GSH) and oxidized (GSSG) states. GSH is a substrate in conjugation and reduction
reactions catalyzed by glutathione S-transferase enzymes located in cytosol, microsomes, and
mitochondria. Interestingly, MPiφs showed a 3.4-fold upregulation of xanthine dehydrogenase
mRNA expression (S1 Table) and increased expression of 8 types of glutathione S-transferase
(Fig 4A). MPiφs also showed upregulated mRNA levels of two enzymes involved in GSH syn-
thesis and several enzymes involved in the GSH/GSSG cycle (Fig 4A). Consistent with these
observations, MPiφs had a significantly higher total antioxidant capacity (Fig 4B) and a higher
GSH/GSSG ratio (Fig 4C), whereas total GSH levels were not significantly altered (Fig 4D).
MPiφs prevent calcium-phosphate deposition
Calcium-phosphate deposition (CPD) is inhibited both in vitro and in vivo by extracellular
ATP[35] and pyrophosphate (PPi)[26], which is produced mainly from the hydrolysis of extra-
cellular ATP[36]. We recently demonstrated that M2φs, but not M1φs, have an anti-calcifying
activity dependent on increased availability of extracellular ATP and PPi[24].
The arginine degradation and the energetic and antioxidant profiles revealed by the RNA-
seq data and functional studies indicate that MPiφs have more in common with M2φs than
with M1φs. This suggested that MPiφs might prevent CPD by increasing the availability of
extracellular ATP and PPi. Supporting this idea, MPiφs produced higher levels of extracellular
ATP and PPi than M0φs, with no significant differences in extracellular PPi/ATP ratio (Fig
5A–5C). Moreover, in a co-culture model of passive CPD with fixed VSMCs, MPiφs reduced
the amount of deposited calcium to a significantly greater extent than M0φs (Fig 5D, -AP).
Hydrolysis of extracellular polyphosphates by treatment of co-cultures with alkaline phospha-
tase significantly increased CPD to the level seen in the absence of macrophages (Fig 5D,
+AP).
These results suggested that MPiφ-mediated protection against CPD is due to the increased
availability of extracellular ATP and PPi. The main ectoenzymes involved in the regulation of
extracellular ATP and PPi metabolism include 1) ectonucleotide pyrophosphatase/phosphodi-
esterase 1 (eNPP1), which produces PPi from ATP hydrolysis; 2) tissue non-specific alkaline
phosphatase (TNAP), which produces Pi from PPi hydrolysis; and 3) ectonucleoside triphos-
phate diphosphohydrolase 1 (eNTPD1), which produces Pi from ATP hydrolysis. Analysis by
qPCR revealed similar levels of eNPP1 mRNA in M0φs and MPiφs (Fig 6A). In contrast, com-
pared with M0φs, MPiφs expressed *3.4-fold higher levels of eNTPD1 and *3.2-fold lower
Phosphate-activated macrophages and ectopic calcification
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levels of TNAP (Fig 6A). These differences were confirmed at the protein level by immunoblot,
showing a *1.7-fold higher expression ofeNTPD1 and a *1.9-fold lower amount of TNAP in
MPiφs (Fig 6B). We also measured the accumulation of extracellular PPi 1h after incubating
M0φs or MPiφs with 1μmol/L ATP. In agreement with the qPCR and immunoblot data,
MPiφs showed higher eNTPD activity (revealed by *2-fold lower production of extracellular
PPi)(Fig 6C), and*1.8-fold lower alkaline phosphatase activity (Fig 6D).
Fig 4. MPiφs show elevated antioxidant synthesis. (A) RNAseq data summarizing fold mRNA downregulation or upregulation in MPiφs of enzymes
involved in glutathione metabolism. (B) Total antioxidant capacity. (C) GSH/GSSG ratio. (D) Total GSH. Statistical significance was determined
Student’s t-test. Results are presented as mean ± SE of 4 independent experiments with 3 mice per experiment. *, P<0.05; **, P<0.01.
https://doi.org/10.1371/journal.pone.0174998.g004
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Fig 5. MPiφs prevent calcium-phosphate deposition by increasing extracellular ATP and PPi. Fixed VSMCs were incubated in pro-calcifying
medium over 5 days with 0.4 μm polycarbonate transwells containing unpolarized M0φsor Pi-activated MPiφs. (A, B) Extracellular ATP and PPi released
by the indicated macrophage types. (C) PPi/ATP ratio. Statistical significance was determined by unpaired Student’s t-test. Results are presented as
mean ± SE of 3 independent experiments with 3 mice per experiment. (D) Calcium deposition on fixed VSMCs in absence (Control) or presence of M0φs
or MPiφs. Experiments were performed in the presence or absence of exogenous alkaline phosphatase (-AP and +AP). Statistical significance was
determined by one-way ANOVA analysis of variance followed by Tukey’s multicomparison test. Results are presented as mean ± SE of 4 independent
experiments with 3 mice per experiment. *, P<0.05; **, P<0.01; ***, P<0.001.
https://doi.org/10.1371/journal.pone.0174998.g005
Phosphate-activated macrophages and ectopic calcification
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Discussion
CPD, mainly in the form of hydroxyapatite or whitlockite, is the hallmark of calcification.
Physiological CPD occurs in specific sites of hard tissues such as bone, antlers, and dentine.
Soft tissues are not normally mineralized, but aging and several pathological conditions are
associated with soft tissue calcification, which increases morbidity and mortality[2]. Elevated
serum Pi is a key risk factor for pathological and ectopic soft tissue calcification[6]. Calcifica-
tion is associated with the presence of macrophages, but our recent work showed that alter-
natively activated macrophages have an anti-calcifying effect[24]. We hypothesized that
macrophages activated by high Pi concentration might influence ectopic calcification. In this
study, we show for the first time that mouse macrophages are activated by Pi in a dose-
dependent manner (Fig 1). Remarkably, this activation takes at least four days to become
Fig 6. Extracellular PPi metabolism in MPiφs. (A) mRNA levels for the indicated ectoenzymes in unpolarized M0φs and Pi-activated MPiφs. (B)
Immunoblot analysis of the indicated ectoenzymes. Relative levels were quantified by densitometry and were normalized to α–tubulin. (C) eNTPD
activity, quantified as PPi produced from hydrolysis of 1 μmol/L ATP in 1h. (D) Alkaline phosphatase activity. Statistical significance was determined
by unpaired Student’s t-test. Results are presented as mean ± SE of 4 independent experiments with 3 mice per experiment. ATP, adenosine
triphosphate; AMP, adenosine monophosphate; PPi, pyrophosphate; Pi, inorganic phosphate; eNPP1, ectoenzyme nucleotide pyrophosphatase/
phosphodiesterase-1; eNTPD1, ectonucleoside triphosphate diphosphohydrolase 1; TNAP, tissue non-specific alkaline phosphatase. **, P<0.01;
***, P<0,001.
https://doi.org/10.1371/journal.pone.0174998.g006
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manifest, thereby simulating a subacute hyperphosphatemia. Pi-dependent activation of
M0φs is mainly characterized by the elevated expression and activity of Arginase 1, a marker
of mouse M2φs that is not expressed in M1φs[18]. Moreover, MPiφs showed higher mRNA
expression of HIF-1α and PGC-1β, known markers of glycolysis and β-oxidation, respectively
[33,34], and this was associated with increased amounts of intracellular and extracellular
ATP (Figs 3C and 5B), as also occurs in M2φs[24].
Three subclasses of M2φs have been identified, M2a, M2b, and M2c, which differ in their
mode of stimulation and the subsequent expression of surface molecules and cytokines[17,19].
For example, M2a (induced by IL-4 or IL-13) express Arginase 1, whereas M2b (induced by
immune complexes in combination with IL-1β or LPS) express the anti-inflammatory IL-10,
and M2c (induced by IL-10, TGFβ, or glucocorticoids) express CD163. In contrast, classically-
activated M1φs release pro-inflammatory cytokines, including IL-1, IL-6, IL-12, and TNFα.
Macrophages can also be classified into three groups according to their homeostatic activities:
1) M2a subclass (wound-healing macrophages), with tissue repair activity; 2) M2b/c subclass
(regulatory macrophages), with anti-inflammatory activity; and 3) M1φs, (pro-inflammatory
macrophage) with inflammatory and microbicide activity. Interestingly, MPiφs increase the
expression of IL-1α (20.7-fold) and its natural antagonist IL1-Ra (15.7-fold; S1 Table). More-
over, MPiφs express high levels of two interleukin receptors: 1) IL-7R (*18-fold), which is
associated with several diseases including multiple sclerosis, rheumatoid arthritis and juvenile
idiopathic arthritis; and 2) interleukin-1 receptor-like 2 (10.8-fold), which is unable to bind IL-
1α with high affinity. Our data thus show that MPiφs, like wound-healing macrophages, have
an inflammatory-neutral cytokine profile. MPiφs also have a high capacity to repair tissues due
to the high expression of several collagen types (VIIIα1, 16.2-fold; Vα1, 3.7-fold; Vα2, 3.3-fold;
IIIα1, 2.4-fold; and IVα3, 1.7-fold), as well as several matrix metalloproteinases (MMPs)
(MMP8, 17.2-fold; MMP12, 11.8-fold; MMP13, 10.5-fold; MMP3, 6.6-fold; and MMP27,
5.6-fold).
From a functional perspective, M1φs participate in the removal of pathogens during infec-
tion through the activation of the NADPH oxidase (NOX) system and the subsequent genera-
tion of ROS, which cause significant damage to cellular structures. Our results show that
MPiφs down regulate Nox1 (3.4-fold) and upregulate several antioxidant enzymes that protect
against oxidative stress, including catalase, xanthine dehydrogenase, two superoxide dismu-
tases, two glutathione peroxidases, and eight glutathione S-transferases (see S1 Table). Consis-
tent with these observations, MPiφs have an elevated total antioxidant capacity and a high
GSH/GSSG ratio (Fig 4). We therefore conclude that MPiφs have a role unlike that of M1φs in
terms of the ROS generation, and have an antioxidant gene expression profile similar to that of
oxidized LDL-stimulated macrophages (Mox).
We recently reported that IL-4-activated M2φs (wound-healing macrophages) have an
anti-calcifying activity that protects against CPD during ectopic calcification[24]. M2φ-depen-
dent prevention of CPD is due to elevated amounts of extracellular PPi and ATP, resulting
respectively from increased eNPP1 activity and of fatty acid β-oxidation. The present results
show that MPiφs, likeIL-4-activated M2φs, prevent CPD in vitro via an increased availability
of extracellular ATP and PPi. However, unlike M2φs, MPiφs increase extracellular PPi (Fig
5B) without significantly increasing its synthesis (Fig 5C), operating instead by decreasing
expression and activity of TNAP (Fig 6), the enzyme that degrades PPi to form Pi. This reduc-
tion in TNAP activity in MPiφs may compensate the increased expression and activity of
eNTPD1, the enzyme that directly competes with eNPP1 for extracellular ATP and releases Pi
(not PPi) from its hydrolysis.
In conclusion, we have identified a phenotypic change in macrophages that is induced by
hyperphosphatemia (MPiφs). The enhanced arginine hydrolysis in MPiφs and their energetic
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and antioxidant profiles together suggest classification as a new subclass of M2φs, with tissue
repair and anti-calcifying activity elicited by increased accumulation of extracellular ATP/PPi.
This capacity to prevent CPD could be a compensatory mechanism to protect tissues against
Pi-induced calcification (Fig 7).
Supporting information
S1 Table. RNAseq analysis. Gene expression profiles of MPiφs and M0φs revealed 3,270
mRNAs differentially expressed in MPiφs versus M0φs.
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